Sign in
4

Changes in Ownership

Vir Biotechnology, Inc. Filed Acc 0001628280-26-022971

Director sold 22,000 shares at $9.07 ($199,617)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
SATO VICKI L Director 2026-04-01 Sale 10b5-1 −22,000 $9.07 $199,617 1,100,391 D
Open-market sales · 22,000 sh · avg $9.07 · $199,617
Loading xslF345X06/wk-form4_1775141198.xml…